With antimicrobial resistance rising as one of the world's most pressing health threats, the 8th World Congress on Targeting ...

Biomx Inc., a company specializing in phage therapy, presented its first-quarter earnings call for 2025, highlighting significant progress in its clinical trials and strategic initiatives.

BiomX's BX211 virus therapy shows promise in Phase 2 trial, reducing foot ulcer size in diabetic bone infection patients ...

so their widespread prevalence makes them a promising target for developing strategies to bolster the effectiveness of phage therapy. "If we target phage defense systems present in bacteria to ...

Although the advent and mass production of antibiotics caused a decline in phage therapy, the recent rise in antibiotic resistance has renewed the global interest in this line of treatment. In this ...

Nonetheless, there are several challenges that must be addressed prior to widespread adoption of phage therapy. In this section, the authors consider various strategies of phage formulation ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

The Nevada Assembly Health and Human Services Committee is set to review Assembly Bill 378, a proposed legislation aimed at establishing an Alternative Therapies Pilot Program for veterans and ...

Phage biology is the scientific discipline concerned with the study of all biological aspects of bacteriophages (phages), which are viruses that infect bacteria. This includes the distribution ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

FMT is a novel therapeutic approach that involves transferring microbiota from a healthy donor to a patient's ...